Overview Depakote-ER for Depressive and Bipolar Depression Status: Completed Trial end date: 2006-08-01 Target enrollment: Participant gender: Summary Obtain information using a randomized treatment to assess the antidepressant and anxiolytic efficacy of divalproex vs. placebo for nonrefractory bipolar patients with major depressive episodes. Phase: Phase 4 Details Lead Sponsor: Cambridge Health AllianceCollaborator: Northwestern UniversityTreatments: Valproic Acid